Filtered By:
Therapy: Corticosteroid Therapy

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 2470 results found since Jan 2013.

Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
Intern Med. 2023 Aug 16. doi: 10.2169/internalmedicine.1648-23. Online ahead of print.ABSTRACTPulmonary and extrapulmonary complications after coronavirus disease 2019 (COVID-19) have been major public health concerns during the COVID-19 pandemic. Although post-COVID-19 pulmonary manifestations cover a wide spectrum, eosinophilic pneumonia (EP) has rarely been reported. To date, only four cases of EP potentially triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported, all of which required systemic corticosteroid therapy. We herein report the first case of post-COVID-19 EP res...
Source: Internal Medicine - August 16, 2023 Category: Internal Medicine Authors: Yumiko Misaki Yusuke Hayashi Masahiro Shirata Kazuhiro Terada Akihiko Yoshizawa Ryo Sakamoto Kohei Ikezoe Kiminobu Tanizawa Tomohiro Handa Toyohiro Hirai Source Type: research

Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone
ConclusionThese findings suggest MP treatment could ameliorate levels of myoglobin and FABP3, but appeared to have no impact on HMGB1, TnI and NTproBNP. In addition, methylprednisolone relieves the COVID-19 induced inflammatory response by diminishing MIG and IP-10 levels. Overall, corticosteroid (methylprednisolone) use in COVID-19 management influences the immunological molecule and injury biomarker profile in COVID-19 patients.
Source: Frontiers in Immunology - August 16, 2023 Category: Allergy & Immunology Source Type: research

Nephrotic syndrome following COVID-19 vaccination: a systematic review
CONCLUSION: Further investigations will help in establishing an early diagnosis and salvaging kidney function.PMID:37505405 | DOI:10.1007/s40620-023-01710-z
Source: Journal of Nephrology - July 28, 2023 Category: Urology & Nephrology Authors: Charmy Parikh Henil Upadhyay Suyog Patel Ramaswamy Sundararajan Dhairya Shah Ayush Anand Bhavana Baraskar Tulsi Bhatt Deepak Verma Shubham Agrawal Amol Mittal Sanjeev Gupta Source Type: research

Can Coronavirus Disease 2019 Induce Sarcoidosis: A Case Report
Thorac Res Pract. 2023 Jan;24(1):45-58. doi: 10.5152/ThoracResPract.2023.22076.ABSTRACTSince the emergence of coronavirus disease 2019, a large spectrum of clinical manifestations following this acute viral infection has been reported especially autoimmune manifestations and inflammatory disorders. However, a causal link has not yet been established. Herein, we reported a case of pulmonary mediastinal sarcoidosis following coronavirus disease 2019 infection. A 41-year-old woman with no clinical or radiographic symptoms or signs of sarcoidosis prior to coronavirus disease 2019 infection developed dyspnea, cough, and fatigue...
Source: Cell Research - July 28, 2023 Category: Cytology Authors: Hajer Racil Tasnim Znegui Sarra Maazoui Amany Touil Sonia Habibech Neji Henda Nawel Chaouch Source Type: research

Expression of circulating angiotensin ‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
ConclusionCirculating ACE2 levels in asthmatic children were lower than those in non-asthmatic children and ICS treatment for ≥6 months did not affect the expression of ACE2 in peripheral blood in the asthma children.
Source: Immunity, Inflammation and Disease - July 27, 2023 Category: Allergy & Immunology Authors: Xiang Ma, Lesen Liu, Jing Sun, Yun Zhang, Yanqin Liu, Miao Liu, Bing Wang, Yuna Chang, Yuling Han, Zhongtao Gai Tags: ORIGINAL ARTICLE Source Type: research

A Comparison of the Effects of Dexamethasone and Methylprednisolone, Used on Level-3 Intensive Care COVID-19 Patients, on Mortality: A Multi-Center Retrospective Study
CONCLUSION: Corticosteroids are shown to be beneficial in critical COVID-19, but the role of early corticosteroids in mild COVID-19 patients remains unclear. The anti-inflammatory effects of corticosteroids may have a positive effect by reducing mortality in severe COVID-19 patients. Although dexamethasone was first used for this purpose, methylprednisolone was found to be as effective at standard doses. Methylprednisolone administered at standard doses was associated with greater PaO2/FiO2 ratios than dexamethasone, especially in the severe group requiring MV. High dose pulse steroid doses are closely associated with mort...
Source: Journal of Korean Medical Science - July 25, 2023 Category: Biomedical Science Authors: Ahmet Sari Osman Ekinci Kemal Tolga Sara çoğlu Recep Bal ık Mesut Aslan Yelda Bal ık Ceren Önal Murat Aslan Semra Cevher Aylin Parmaks ız Şeule Vatansever M ünire Canan Çicek Özge Sayın Ayan Gaye Şensöz Çelik A çelya Toprak Mehmet Y ılmaz Source Type: research